Abstract
Objective
Hyperglycemia in preterm infants is usually treated with adjustment of glucose intake and, if persistent, with continuous insulin infusion. However, hypoglycemia is a well-known complication of intravenous (iv) insulin treatment. The aim of this study was to evaluate the feasibility of continuous subcutaneous insulin infusion (CSII) in extremely preterm infants.
Methods
Clinical data from extremely premature infants (<28 weeks of gestation) undergoing CSII treatment for severe hyperglycemia in the neonatal intensive care unit were included. Blood glucose levels during CSII, as well as the nutritional intake and insulin intake were recorded. Data were analyzed and compared to a control group of very preterm infants receiving iv insulin therapy.
Results
Normoglycemia rates were best in the iv insulin-cohort (n=22, 50.3%) compared to the CSII group (n=15, 15.6%). Hypoglycemia was very rare in both groups (0.4% vs. 0.0%). CSII therapy appears to require higher insulin doses compared to continuous iv therapy to achieve a similar effect. Subcutaneous Insulin therapy in extremely preterm infants is feasible, at least for prevention of hypoglycemia. However, dose control needs to be improved.
Conclusion
The results justify further model validation and clinical trial research to explore a model-based protocol and the use of CSII in this population.
Keywords: Continuous subcutaneous insulin infusion, extremely preterm infants, hyperglycemia
Read the full text
5 sections · 2 figures · 1 table · PDF
Create your free account to read the full text.
- Full text with figures and tables
- PDF and supplementary files
- Access on every Galenos journal
One Galenos account works on every Galenos journal site.
References
Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, Vanhole C, Palmer CR, Ong K, vanWeissenbruch M, Midgley P, Thompson M, Thio M, Cornette L, Ossuetta I, Iglesias I, Theyskens C, de Jong M, Gill B, Ahluwalia JS, de Zegher F, Dunger DB. Prevalence and determinants of hyperglycemia in very low birth weight infants: cohort analyses of the NIRTURE study. J Pediatr. 2010;157:715-719. Epub 2010 Jun 8
Ditzenberger GR, Collins SD, Binder N. Continuous insulin intravenous infusion therapy for VLBW infants. J Perinat Neonatal Nurs. 1999;13:70-82.
Zamir I, Tornevi A, Abrahamsson T, Ahlsson F, Engström E, Hallberg B, Hansen-Pupp I, Sjöström ES, Domellöf M. Hyperglycemia in Extremely Preterm Infants-Insulin Treatment, Mortality and Nutrient Intakes. J Pediatr. 2018;200:104-110. Epub 2018 May 3
Alexandrou G, Skiöld B, Karlén J, Tessma MK, Norman M, Adén U, Vanpée M. Early hyperglycemia is a risk factor for death and white matter reduction in preterm infants. Pediatrics. 2010;125:584-591. Epub 2010 Feb 22
Segerer H, Bührer C, Kapellen T, Mattern E, Ramsauer B, Somville T, Trotter A. Betreuung von Neugeborenen diabetischer Mütter. Leitlinie der GNPI, DGPM, DDG, DGHWi, dem DHV, der DGKJ und DGGG. (2k-Level, AWMF-Leitlinien-Register Nr. 024/006, Juli 2017). Z Geburtshilfe Neonatol. 2018;222:107-114. Epub 2018 Jun 19
Beardsall K, Thomson L, Elleri D, Dunger DB, Hovorka R. Feasibility of automated insulin delivery guided by continuous glucose monitoring in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2020;105:279-284. Epub 2019 Aug 9
Ogilvy-Stuart AL, Beardsall K. Management of hyperglycaemia in the preterm infant. Arch Dis Child Fetal Neonatal Ed. 2010;95:126-131.
Beardsall K, Ogilvy-Stuart AL, Ahluwalia J, Thompson M, Dunger DB. The continuous glucose monitoring sensor in neonatal intensive care. Arch Dis Child Fetal Neonatal Ed. 2005;90:307-310.
van der Lugt NM, Smits-Wintjens VE, van Zwieten PH, Walther FJ. Short and long term outcome of neonatal hyperglycemia in very preterm infants: a retrospective follow-up study. BMC Pediatr. 2010;10:52.
Szymońska I, Jagła M, Starzec K, Hrnciar K, Kwinta P. The Incidence Of Hyperglycaemia In Very Low Birth Weight Preterm Newborns. Results of A Continuous Glucose Monitoring Study--Preliminary Report. Dev Period Med. 2015;19:305-312.
Fernández-Martínez MDM, Gómez-Llorente JL, Momblán-Cabo J, Martin-González M, Calvo-Bonachera M, Olvera-Porcel M, Bonillo-Perales A. Monitoring the incidence, duration and distribution of hyperglycaemia in very-low-birth-weight newborns and identifying associated factors. J Perinat Med. 2020;48:631-637.
Ng SM, May JE, Emmerson AJ. Continuous insulin infusion in hyperglycaemic extremely-low- birth-weight neonates. Biol Neonate. 2005;87:269-272. Epub 2005 Feb 4
Alsweiler JM, Harding JE, Bloomfield FH. Tight glycemic control with insulin in hyperglycemic preterm babies: a randomized controlled trial. Pediatrics. 2012;129:639-647. Epub 2012 Mar 19
Hewson M, Nawadra V, Oliver J, Odgers C, Plummer J, Simmer K. Insulin infusions in the neonatal unit: delivery variation due to adsorption. J Paediatr Child Health. 2000;36:216-220.
Wilson D, Mc Clure G. Continuous Insulin Infusion is Safe and Efficacious in the Hyperglycemic ELBW Infant: Results of a RCT † 1587. Pediatr Res. 1999;43(Suppl 4):271.
Wintergerst KA, Hargadon S, Hsiang HY. Continuous subcutaneous insulin infusion in neonatal diabetes mellitus. Pediatr Diabetes. 2004;5:202-206.
Beardsall K, Pesterfield CL, Acerini CL. Neonatal diabetes and insulin pump therapy. Arch Dis Child Fetal Neonatal Ed. 2011;96:223-224. Epub 2010 Nov 29
Dorling J, Abbott J, Berrington J, Bosiak B, Bowler U, Boyle E, Embleton N, Hewer O, Johnson S, Juszczak E, Leaf A, Linsell L, McCormick K, McGuire W, Omar O, Partlett C, Patel M, Roberts T, Stenson B, Townend J; SIFT Investigators Group. Controlled Trial of Two Incremental Milk-Feeding Rates in Preterm Infants. N Engl J Med. 2019;381:1434-1443.
Paulsen ME, Brown SJ, Satrom KM, Scheurer JM, Ramel SE, Rao RB. Long-Term Outcomes after Early Neonatal Hyperglycemia in VLBW Infants: A Systematic Review. Neonatology. 2021;118:509-521. Epub 2021 Aug 19
Caldas JP, Braghini CA, Mazzola TN, Vilela MM, Marba ST. Peri-intraventricular hemorrhage and oxidative and inflammatory stress markers in very-low birth weight newborns. J Pediatr (Rio J). 2015;91:373-379. Epub 2015 Apr 23
Ostertag SG, Jovanovic L, Lewis B, Auld PA. Insulin pump therapy in the very low birth weight infant. Pediatrics. 1986;78:625-630.
Meetze W, Bowsher R, Compton J, Moorehead H. Hyperglycemia in extremely- low-birth-weight infants. Biol Neonate. 1998;74:214-221.
Kao LS, Morris BH, Lally KP, Stewart CD, Huseby V, Kennedy KA. Hyperglycemia and morbidity and mortality in extremely low birth weight infants. J Perinatol. 2006;26:730-736. Epub 2006 Aug 24
Zamir I, Stoltz Sjöström E, Ahlsson F, Hansen-Pupp I, Serenius F, Domellöf M. Neonatal hyperglycaemia is associated with worse neurodevelopmental outcomes in extremely preterm infants. Arch Dis Child Fetal Neonatal Ed. 2021;106:460-466. Epub 2021 Apr 16
Knopp Nee Dickson JL, Lynn AM, Shaw GM, Chase JG. Safe and effective glycaemic control in premature infants: observational clinical results from the computerised STAR-GRYPHON protocol. Arch Dis Child Fetal Neonatal Ed. 2019;104:205-211. pub 2018 Jun 21
Zhou T, Boettger M, Knopp JL, Lange M, Heep A, Chase JG. Model-based subcutaneous insulin for glycemic control of pre-term infants in the neonatal intensive care unit. Comput Biol Med. 2023;160:106808. Epub 2023 Mar 21
